Information Collection
Testing FDA's Drug Safety Communications with Consumers to Improve Consumer Knowledge about How FDA Communicates Risks and Benefits of Prescription Medicines
IC 212699 under ICR 201604-0910-008 · OMB 0910-0677.
⚠️ Notice: This information collection may be referencing outdated material. More recent filings for OMB 0910-0677 can be found here:
Documents and Forms
| Document Name | Document Type |
|---|---|
| Other-Screener | |
| Other-Moderator's guide | |
|
DSC Example 1 testosterone | IC Document |
|
DSC Example 2 Sodium Phosphate | IC Document |
|
DSC Example 3 Fentanyl | IC Document |
|
DSC Testosterone pdf | IC Document |
|
DSC Sodium Phosphate pdf | IC Document |
|
DSC Fentanyl | IC Document |
|
OMB Memo/Abbreviated supporting statement | IC Document |